Page Inspect

Amgen | A Worldwide Pioneer in Biotechnology



# Amgen | A Worldwide Pioneer in Biotechnology



-
- Main Menu
- About
- Overview
- Amgen History
- Mission and Values
- Leadership
- Amgen Foundation
- Awards and Accolades
- Therapy Areas
- Cardiovascular Metabolic
- Bone Health
- Inflammation
- Oncology
- How We Operate
- Overview
- Corporate Governance
- Business Ethics and Compliance
- Policies, Practices and Disclosures
- Science
- Overview
- Research & Development Strategy
- Overview
- Human & Disease Biology
- Novel Targets & Modalities
- Clinical Trial Optimization
- AI & Data Science
- Pipeline
- Scientific Advisory Boards
- Biosimilars
- Clinical Trials
- Overview
- About Clinical Trials
- Amgen Clinical Trials
- Clinical Trial Diversity and Representation
- Information for Healthcare Professionals
- Clinical Trial Transparency, Data Sharing and Disclosure Practices
- Clinical Out-of-Hours Support program
- Investigator Sponsored Studies
- Scientific Community Initiatives
- Overview
- Educational Outreach Program
- Postdoctoral Fellows Program
- Scientific Conferences Program
- Start-Up Network Program
- Manufacturing
- Overview
- Innovation
- Quality
- Reliability
- PRODUCTS
- Overview
- Medical Information
- Counterfeit Drug Statement
- Safety Data Sheets
- Global Patient Safety
- Overview
- Who We Are
- Our Commitment
- What We Do
- Adverse Event and Product Complaint Reporting
- Responsibility
- Overview
- 2024 Sustainability Highlights Report
- Environment, Social and Governance Strategy
- Healthy People
- Overview
- Access to Healthcare
- Health Equity
- Healthy Society
- Overview
- Diversity, Inclusion and Belonging
- Human Capital Management
- Community Investment and Amgen Foundation
- Healthy Planet
- Overview
- Environmental Sustainability
- Responsible Sourcing
- Healthy Amgen
- Overview
- Corporate Governance
- Business Ethics and Compliance
- Ethical Research and Development
- Patient Safety
- Product Quality
- Cybersecurity and Data Privacy
- Reporting and Metrics
- Overview
- CDP
- Archived Reports
- Stories
- All Stories
- Responsibility
- People and Culture
- Science and Innovation
- Patients
- Leadership
- Newsroom
- Partners
- Investors
- Careers
- Amgen Worldwide

- -
-
-
-
-

- Overview
- Research & Development Strategy
- Overview <i class="fa fa-external-link"></i>
- Scientific Advisory Boards
-
- Clinical Trials
- Scientific Community Initiatives&nbsp;&nbsp;&nbsp;
- Manufacturing



- About

- Overview
- Amgen History
- Mission and Values
- Leadership
- Amgen Foundation

- Therapy Areas
- General Medicine
- Rare Disease
- Inflammation
- Oncology

- Awards and Accolades
- How We Operate
- Corporate Governance
- Business Ethics and Compliance
- Policies, Practices and Disclosures
- Science

- Overview
- Research & Development Strategy
- Human & Disease Biology
- Novel Targets & Modalities
- Clinical Trial Optimization
- AI in Research & Development
- Pipeline
- Scientific Advisory Boards
- Biosimilars

- Clinical Trials
- About Clinical Trials
- Amgen Clinical Trials
- Clinical Trial Diversity and Representation
- Information for Healthcare Professionals
- Clinical Trial Transparency, Data Sharing and Disclosure Practices
- Clinical Out-of-Hours Support Program
- Investigator Sponsored Studies

- Scientific Community Initiatives
- Educational Outreach Program
- Postdoctoral Fellows Program
- Scientific Conferences Program
- Start-Up Network Program
- Manufacturing
- Innovation
- Quality
- Reliability
- PRODUCTS

- Overview
- Medical Information
- Counterfeit Drug Statement
- Safety Data Sheets

- Global Patient Safety
- Who We Are
- Our Commitment
- What We Do
- Adverse Event and Product Complaint Reporting
- Responsibility

- Overview
- 2024 Sustainability Highlights Report
- Corporate Sustainability Strategy
- Healthy People
- Access to Healthcare
- Health Equity

- Healthy Society
- Amgen Foundation and Community Investment
- Diversity, Inclusion and Belonging
- Human Capital Management

- Healthy Planet
- Environmental Sustainability
- Responsible Sourcing

- Healthy Amgen
- Corporate Governance
- Business Ethics and Compliance
- Ethical Research and Development
- Patient Safety
- Product Quality
- Cybersecurity and Data Privacy
- Reporting and Metrics
- CDP
- Archived Reports
- Stories

- All Stories
- Responsibility
- People and Culture
- Science and Innovation
- Patients
- Leadership
- Newsroom
- Partners
- Investors
- Careers
-
-

X

Responsibility 11.13.2025

## Delivering Excellence: Celebrating Quality, Safety & Compliance Month at Amgen

Read Story

❮1 / 6❯

Responsibility 11.11.2025

## For Fifth Straight Year, Amgen Foundation Doubles Down on Giving Tuesday

Read Story

❮2 / 6❯

Press Release 11.08.2025

## Amgen's Repatha® Cuts Risk of First Major Adverse Cardiovascular Events by 25% in Landmark Phase 3 VESALIUS-CV Trial

Read Release

❮3 / 6❯

Press Release 11.04.2025

## Amgen Announces 2025 Third Quarter Financial Results

Read More

View Webcast

❮4 / 6❯

Responsibility 11.03.2025

## Amgen Foundation Renews Commitment to Signature Amgen Scholars Program

Read Story

❮5 / 6❯

Science & Innovation 10.31.2025

## Amgen Breaks Ground on $600 Million Center for Science and Innovation in Thousand Oaks, Calif.

Read Story

❮6 / 6❯

PATIENTS 10.22.2025

## Honoring Peggy: Senior Leader Emily Razaqi Shares a Personal Story for Breast Cancer Awareness Month

PATIENTS 10.20.2025

## A Bold Goal for Stronger Bones: Preventing 3 Million Fractures by 2033

PATIENTS 10.13.2025

## Aanika's Journey: Life After a Severe Asthma Diagnosis

PATIENTS 10.01.2025

## From Breakthrough Science to Real-World Impact: Amgen's Legacy in Cardiovascular Disease Care

RESPONSIBILITY 09.29.2025

## Amgen Employees Making a Difference on Land and Sea: 20 Years of Coastal Cleanup

PRESS RELEASE 09.26.2025

## Amgen Announces $650M Expansion of U.S. Manufacturing, Creating Hundreds of New Jobs

SCIENCE & INNOVATION 09.23.2025

## Induced Proximity: Turning Molecular Matchmakers into Medicines

RESPONSIBILITY 09.18.2025

## Championing Change: Amgen’s Commitment to Blood Cancer Care in Hispanic Communities

LEADERSHIP 06.05.2025

## Meet the Woman Leading the Obesity and Related Conditions Team at Amgen

MORE STORIES

### Our Latest Press Releases

PRESS RELEASE

PRESS RELEASE

PRESS RELEASE

PRESS RELEASE

PRESS RELEASE

More News



##### Global hotline for Ukrainian refugee patients participating in an Amgen clinical trial.
##### Click here for more information.

## Our Story
Watch VideoLearn more

## Our Science

Amgen is a pioneer in the science of using living cells to make biologic medicines.


READ MORE

## Our Products

Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.

READ MORE

## Our Responsibility

Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.

READ MORE

## Amgen Investors

Amgen is a pioneer in the science of using living cells to make biologic medicines, leading and guiding the biotech industry.

Read More

## Careers With Amgen

Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.

Read More



### Follow Us On Social Media

-
-
-
-
-

Contact Us Sitemap Privacy Statement Terms of Use Consumer Health Data Privacy Policy Your Cookie Preferences

© 1996-2025 Amgen Inc. All rights reserved.